BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2057540)

  • 1. Stability and pharmacokinetics of flumazenil in the rat.
    Mandema JW; Gubbens-Stibbe JM; Danhof M
    Psychopharmacology (Berl); 1991; 103(3):384-7. PubMed ID: 2057540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative pharmacokinetics of submucosal vs. intravenous flumazenil (Romazicon) in an animal model.
    Oliver FM; Sweatman TW; Unkel JH; Kahn MA; Randolph MM; Arheart KL; Mandrell TD
    Pediatr Dent; 2000; 22(6):489-93. PubMed ID: 11132509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flumazenil kinetics in the elderly.
    Roncari G; Timm U; Zell M; Zumbrunnen R; Weber W
    Eur J Clin Pharmacol; 1993; 45(6):585-7. PubMed ID: 8157048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of the new benzodiazepine antagonist Ro 15-1788 in man following intravenous and oral administration.
    Roncari G; Ziegler WH; Guentert TW
    Br J Clin Pharmacol; 1986 Oct; 22(4):421-8. PubMed ID: 3094572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flumazenil disposition and elimination in cirrhosis.
    Janssen U; Walker S; Maier K; von Gaisberg U; Klotz U
    Clin Pharmacol Ther; 1989 Sep; 46(3):317-23. PubMed ID: 2505960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of flumazenil-precipitated abstinence on the pharmacokinetics of chronic oxazepam in dogs.
    Wala EP; Sloan JW; Martin WR; Pruitt TA
    Pharmacol Biochem Behav; 1990 Feb; 35(2):347-50. PubMed ID: 2108448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of the anti-AIDS drug 2',3'-dideoxyinosine in the rat.
    Ray GF; Mason WD; Badr MZ
    Drug Metab Dispos; 1990; 18(5):654-8. PubMed ID: 1981715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of flumazenil and midazolam.
    Jones RD; Chan K; Roulson CJ; Brown AG; Smith ID; Mya GH
    Br J Anaesth; 1993 Mar; 70(3):286-92. PubMed ID: 8471371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of (-)-(S)-bromofosfamide after intravenous and oral administration in mice.
    Kobylińska K; Kobylińska M; Sobik B
    Arzneimittelforschung; 2001; 51(7):596-9. PubMed ID: 11505792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single dose pharmacokinetics and bioavailability of glucosamine in the rat.
    Aghazadeh-Habashi A; Sattari S; Pasutto F; Jamali F
    J Pharm Pharm Sci; 2002; 5(2):181-4. PubMed ID: 12207871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of cyanamide in dog and rat.
    Obach R; Colom H; Arso J; Peraire C; Pruñonosa J
    J Pharm Pharmacol; 1989 Sep; 41(9):624-7. PubMed ID: 2573707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug interactions and clinical pharmacokinetics of flumazenil.
    Klotz U
    Eur J Anaesthesiol Suppl; 1988; 2():103-8. PubMed ID: 2842128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and clinical use of flumazenil (Ro 15-1788).
    Klotz U; Kanto J
    Clin Pharmacokinet; 1988 Jan; 14(1):1-12. PubMed ID: 3127102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rapid high-pressure liquid chromatographic procedure for determination of flumazenil in plasma.
    Zedkova L; Rauw GA; Baker GB; Coupland NJ
    J Pharmacol Toxicol Methods; 2001; 46(1):57-60. PubMed ID: 12164261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral idazoxan bioavailability in rat. Relevance of intestinal and hepatic first-pass effect.
    Vallès J; Pruñonosa J; Menargues A; Nomen M; Obach R
    Drug Metab Dispos; 1989; 17(6):673-6. PubMed ID: 2575506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics and oral bioavailability studies of columbianetin in rats after oral and intravenous administration.
    Luo Q; Wang CP; Li J; Ma WF; Bai Y; Ma L; Gao XM; Zhang BL; Chang YX
    J Ethnopharmacol; 2013 Oct; 150(1):175-80. PubMed ID: 23994338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral and intravenous trichloroethylene pharmacokinetics in the rat.
    D'Souza RW; Bruckner JV; Feldman S
    J Toxicol Environ Health; 1985; 15(5):587-601. PubMed ID: 4046066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of pidotimod in rats and dogs.
    Coppi G; Silingardi S
    Arzneimittelforschung; 1994 Dec; 44(12A):1460-4. PubMed ID: 7857342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma pharmacokinetics and metabolism of the benzodiazepine antagonist [11C] Ro 15-1788 (flumazenil) in baboon and human during positron emission tomography studies.
    Debruyne D; Abadie P; Barre L; Albessard F; Moulin M; Zarifian E; Baron JC
    Eur J Drug Metab Pharmacokinet; 1991; 16(2):141-52. PubMed ID: 1657612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in patients with hepatic cirrhosis.
    Hayton WL; Kneer J; Blouin RA; Stoeckel K
    Antimicrob Agents Chemother; 1990 Jul; 34(7):1318-22. PubMed ID: 2386364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.